Pharma

Taking stock of the drug industry, from the lab to the medicine chest

Insulin factory - Novo
Pharmalot

One-quarter of people with diabetes in the U.S. are rationing their insulin

By Ed Silverman

Pharmalot

Pharmalittle: Roche hits milestone with personalized cancer drug; data on a fountain of youth drug

By Ed Silverman

Rep. Elijah Cummings
Pharmalot

With eyes on Gilead, lawmakers want details on how HHS reviews possible patent infringement

By Ed Silverman

Hoarding Opioids
Pharmalot

New proposal looks to involve every local U.S. government in opioid settlements

By Ed Silverman

Pharmalot

Pharmalittle: Pfizer to buy Array for $11 billion, Teva settlement in Oklahoma may hit a new snag

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: the latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Bluebird Bio prices gene therapy at $1.8 million; lawmakers urge feds to step up generic probe

By Ed Silverman

Bernie Sanders
Pharmalot

Sanders and Cummings, citing ‘polite f-u letters,’ urge feds to step up probes of generic makers

By Ed Silverman

Copiers
Pharmalot

How a mishap at a photocopier derailed clinical trials and a development deal

By Ed Silverman

Pharmalot

Pharmalittle: Trump offers to help VA negotiate for J&J drug; Senate panel to mark up drug pricing bill

By Ed Silverman

Jennifer Doudna - Genome Editing Conference
Exclusive

GSK partners with CRISPR pioneer Doudna to search for new drugs

By Matthew Herper

Pill pack
Pharmalot

As Amazon seeks to win over health care consumers, its PillPack is accused of violating privacy

By Ed Silverman

FDA; Drug Administration campus
Pharmalot

Catalyst sues FDA over rivals’ drug approval, warning it undermines incentives for rare disease meds

By Ed Silverman

Pharmalot

Pharmalittle: Florida governor signs importation bill; Oklahoma judge nixes Teva opioid settlement

By Ed Silverman

Pharmalot

Pharmalittle: Jacobus price for rare disease drug sets up battle with rival Catalyst; Repatha called cost-effective

By Elizabeth Cooney

Pile of pills in shape of dollar
Pharmalot

Jacobus prices its rare disease drug at half of what Catalyst charges, but will doctors prescribe it?

By Ed Silverman

Pharmalot

Pharmalittle: Roche deal for Spark is delayed again; Insys files for bankruptcy

By Ed Silverman

John Kapoor
Pharmalot

Insys Therapeutics, opioid maker implicated in major kickback scheme, files for bankruptcy

By Ed Silverman

Pharmalot

Pharmalittle: Sanofi picks a new CEO; Juno’s old boss rides again

By Damian Garde

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmacy Benefit Managers
Pharmalot

AIDS groups criticize Express Scripts for excluding several HIV medicines

By Ed Silverman

Pharmalot

Pharmalittle: Insys pays $225 million to settle probes; fewer pharma layoffs so far this year

By Ed Silverman

John N. Kapoor
Pharmalot

Insys agrees to pay $225 million to settle charges of bribing docs and fueling the opioid crisis

By Ed Silverman

Pharmalot

Mallinckrodt to pay $15 million to settle marketing probe, but will fight a charity kickback case

By Ed Silverman

PBM Rebates
Pharmalot

Two more big states take aim at PBM pricing practices, which one lawmaker calls ‘the wild west’

By Ed Silverman

Pharmalot

Pharmalittle: Bristol sets new management team; Pfizer didn’t say drug may reduce Alzheimer’s risk

By Ed Silverman

Jeffrey Leiden
Pharmalot

U.K. patients form a buyer’s club to get a cheaper version of a Vertex cystic fibrosis drug

By Ed Silverman

Pharmalot

Pharmalittle: FDA plans ‘concierge service’ for expanded access to cancer meds; Novartis ‘anchored’ gene therapy price

By Ed Silverman

ASCO 2019 signage
Biotech

What you missed at ASCO? A lot, as cancer research hastens on

By Adam Feuerstein and Matthew Herper

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy